Published in Am J Respir Crit Care Med on October 22, 2010
Innate and adaptive immune responses in asthma. Nat Med (2012) 2.73
An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol (2011) 2.69
A brief history of IL-9. J Immunol (2011) 2.27
Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med (2012) 2.11
Activin A and TGF-β promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol (2012) 1.98
IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med (2013) 1.75
Th9 cells: differentiation and disease. Immunol Rev (2013) 1.61
Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity (2013) 1.43
Pathology of asthma. Front Microbiol (2013) 1.25
The development and in vivo function of T helper 9 cells. Nat Rev Immunol (2015) 1.18
The symphony of the ninth: the development and function of Th9 cells. Curr Opin Immunol (2012) 1.12
The many lives of IL-9: a question of survival? Nat Immunol (2012) 1.11
Role of innate lymphocytes in infection and inflammation. Front Immunol (2012) 1.08
IL-33 induces IL-9 production in human CD4+ T cells and basophils. PLoS One (2011) 1.02
Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS One (2013) 0.99
TH9 cells are required for tissue mast cell accumulation during allergic inflammation. J Allergy Clin Immunol (2015) 0.99
The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells. J Immunol (2015) 0.93
Effects of interleukin-9 blockade on chronic airway inflammation in murine asthma models. Allergy Asthma Immunol Res (2013) 0.93
Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma. Adv Biomed Res (2014) 0.89
Update in asthma 2011. Am J Respir Crit Care Med (2012) 0.89
A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma. Respir Res (2013) 0.88
IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis. PLoS One (2012) 0.88
Innate lymphoid cells and cytokines of the novel subtypes of helper T cells in asthma. Asia Pac Allergy (2014) 0.85
IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis. J Invest Dermatol (2014) 0.85
Maturation of mast cell progenitors to mucosal mast cells during allergic pulmonary inflammation in mice. Mucosal Immunol (2014) 0.84
Key mediators in the immunopathogenesis of allergic asthma. Int Immunopharmacol (2014) 0.84
Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4. Nat Commun (2016) 0.83
Genome-wide expression profiles identify potential targets for gene-environment interactions in asthma severity. J Allergy Clin Immunol (2015) 0.83
Distinct different expression of Th17 and Th9 cells in coxsackie virus B3-induced mice viral myocarditis. Virol J (2011) 0.82
Cyclooxygenase-2 inhibits T helper cell type 9 differentiation during allergic lung inflammation via down-regulation of IL-17RB. Am J Respir Crit Care Med (2013) 0.82
A fusion cytokine coupling GMCSF to IL9 induces heterologous receptor clustering and STAT1 hyperactivation through JAK2 promiscuity. PLoS One (2013) 0.81
Revolution 9: the backwards and forwards evidence surrounding interleukin-9. Am J Respir Crit Care Med (2011) 0.80
Comparison of low-abundance biomarker levels in capillary-collected nonstimulated tears and washout tears of aqueous-deficient and normal patients. Invest Ophthalmol Vis Sci (2013) 0.80
Do mast cells link obesity and asthma? Allergy (2012) 0.80
A deleterious role for Th9/IL-9 in hepatic fibrogenesis. Sci Rep (2016) 0.79
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis. Nat Commun (2017) 0.79
Role of IL-9 and STATs in hematological malignancies (Review). Oncol Lett (2013) 0.79
Association between low expression levels of interleukin-9 and colon cancer progression. Exp Ther Med (2015) 0.78
Tick Salivary Sialostatin L Represses the Initiation of Immune Responses by Targeting IRF4-Dependent Transcription in Murine Mast Cells. J Immunol (2015) 0.77
[Th9 cells. Functionally important or just an epiphenomenon?]. Z Rheumatol (2012) 0.77
Regulation of Th9-type pulmonary immune responses: a new role for COX-2. Am J Respir Crit Care Med (2013) 0.76
Deciphering Asthma Biomarkers with Protein Profiling Technology. Int J Inflam (2015) 0.76
From bench to bedside: Therapeutic potential of interleukin-9 in the treatment of asthma. Exp Ther Med (2017) 0.75
Obesity promotes prolonged ovalbumin-induced airway inflammation modulating T helper type 1 (Th1), Th2 and Th17 immune responses in BALB/c mice. Clin Exp Immunol (2017) 0.75
The puzzle of immune phenotypes of childhood asthma. Mol Cell Pediatr (2016) 0.75
Dynamics of Th9 cells and their potential role in immunopathogenesis of murine schistosomiasis. Parasit Vectors (2017) 0.75
Cutting Edge: IL-25 Targets Dendritic Cells To Attract IL-9-Producing T Cells in Acute Allergic Lung Inflammation. J Immunol (2015) 0.75
Anti-Interleukin-9 Antibody Increases the Effect of Allergen-Specific Immunotherapy in Murine Allergic Rhinitis. Allergy Asthma Immunol Res (2017) 0.75
Neutralization of interleukin-9 ameliorates symptoms of allergic rhinitis by reducing Th2, Th9, and Th17 responses and increasing the Treg response in a murine model. Oncotarget (2017) 0.75
Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis. Chin Med J (Engl) (2017) 0.75
Absence of the common gamma chain (γ(c)), a critical component of the Type I IL-4 receptor, increases the severity of allergic lung inflammation. PLoS One (2013) 0.75
Early local immune defences in the respiratory tract. Nat Rev Immunol (2016) 0.75
Roles of interleukin-9 in the growth and cholecystokinin-induced intracellular calcium signaling of cultured interstitial cells of Cajal. PLoS One (2014) 0.75
The role of iNKT cells on the phenotypes of allergic airways in a mouse model. Pulm Pharmacol Ther (2017) 0.75
Detection of IL-9 producing T cells in the PBMCs of allergic asthmatic patients. BMC Immunol (2017) 0.75
Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med (2002) 6.52
A critical role for eosinophils in allergic airways remodeling. Science (2004) 5.53
Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature (2006) 5.49
Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis (1989) 3.86
Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med (2004) 3.64
Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest (2004) 3.06
Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med (1995) 2.98
Pathogenesis of asthma. Clin Exp Allergy (2008) 2.93
IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity (2000) 2.74
Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med (1998) 2.55
Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med (2003) 2.44
Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol (2005) 2.22
Measuring the lung function in the mouse: the challenge of size. Respir Res (2003) 2.14
Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest (2006) 2.12
Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol (1990) 2.04
Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy (2004) 2.00
Interleukin 9: a candidate gene for asthma. Proc Natl Acad Sci U S A (1997) 1.84
Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med (2002) 1.72
The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J Exp Med (2002) 1.62
Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Respir Cell Mol Biol (1998) 1.60
Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am J Respir Crit Care Med (2000) 1.49
Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J (2002) 1.45
Highly sensitive and specific bioassay for measuring bioactive TGF-beta. BMC Cell Biol (2006) 1.42
Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice. J Immunol (2007) 1.41
Transforming growth factor-beta regulates house dust mite-induced allergic airway inflammation but not airway remodeling. Am J Respir Crit Care Med (2008) 1.40
Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J (1999) 1.38
Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am J Respir Crit Care Med (2007) 1.34
Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta 1. J Immunol (2008) 1.34
Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J Immunol (1998) 1.33
Alpha-4 integrins and VCAM-1, but not MAdCAM-1, are essential for recruitment of mast cell progenitors to the inflamed lung. Blood (2006) 1.32
Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections. Infect Immun (2003) 1.29
Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J Immunol (2009) 1.28
Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis. J Leukoc Biol (1995) 1.27
IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice. Cytokine (2004) 1.19
Silica-directed mast cell activation is enhanced by scavenger receptors. Am J Respir Cell Mol Biol (2006) 1.18
IL-9 induces expression of granzymes and high-affinity IgE receptor in murine T helper clones. J Immunol (1995) 1.17
IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J Immunol (2003) 1.17
Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am J Respir Cell Mol Biol (2001) 1.16
Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol (2001) 1.13
Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. J Allergy Clin Immunol (2007) 1.10
Exaggerated airway narrowing in mice treated with intratracheal cationic protein. J Appl Physiol (1985) (2005) 1.07
Profibrotic effect of IL-9 overexpression in a model of airway remodeling. Am J Respir Cell Mol Biol (2007) 1.05
Components of airway hyperresponsiveness and their associations with inflammation and remodeling in mice. J Allergy Clin Immunol (2007) 1.04
A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters. J Pharmacol Exp Ther (2003) 1.04
Ultrastructural immunolocalization of basic fibroblast growth factor in mast cell secretory granules. Morphological evidence for bfgf release through degranulation. J Histochem Cytochem (1998) 1.03
Mast cells in fibrotic lung disorders. Chest (1993) 1.03
Epithelial expression and release of FGF-2 from heparan sulphate binding sites in bronchial tissue in asthma. Thorax (2004) 0.98
Fibroblast growth factor-2 in remodeling of the developing basement membrane zone in the trachea of infant rhesus monkeys sensitized and challenged with allergen. Lab Invest (2002) 0.94
Mast cells modulate acute ozone-induced inflammation of the murine lung. Am Rev Respir Dis (1993) 0.92
Bleomycin injury of the lung in a mast-cell-deficient model. Agents Actions (1993) 0.82
Differential effects of dexamethasone on the proximal and distal lung response to antigen challenge in allergic cynomolgus monkeys. J Asthma (2008) 0.79
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol (2003) 15.67
Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity (2006) 10.58
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol (2007) 8.33
Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science (2003) 7.49
Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol (2004) 7.22
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature (2002) 6.58
A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med (2007) 6.02
HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol (2010) 5.65
A critical role for eosinophils in allergic airways remodeling. Science (2004) 5.53
Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature (2006) 5.49
Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol (2003) 5.07
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol (2003) 4.66
Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. J Exp Med (2006) 3.76
Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med (2005) 3.48
Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol (2011) 3.35
The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med (2011) 2.87
IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med (2009) 2.78
How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? Respir Med (2005) 2.62
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). J Biol Chem (2006) 2.58
Role of YKL-40 in bronchial smooth muscle remodeling in asthma. Am J Respir Crit Care Med (2012) 2.53
Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J Mol Biol (2007) 2.45
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med (2008) 2.44
Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med (2003) 2.44
CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature (2009) 2.39
Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. Nat Neurosci (2008) 2.38
Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol (2005) 2.22
Mature T cells depend on signaling through the IKK complex. Immunity (2003) 2.21
Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum (2009) 2.14
Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell (2009) 2.10
Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci U S A (2004) 2.09
Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med (2007) 2.08
Type I interferon: potential therapeutic target for psoriasis? PLoS One (2008) 2.08
Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism. J Immunol (2004) 2.06
Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci U S A (2004) 2.00
Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences. J Immunol (2002) 2.00
Activin A and TGF-β promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol (2012) 1.98
NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem (2009) 1.91
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis (2011) 1.91
Of flies, mice and men: a systematic approach to understanding the early life origins of chronic lung disease. Thorax (2012) 1.88
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma. J Allergy Clin Immunol (2010) 1.86
Orchestrating house dust mite-associated allergy in the lung. Trends Immunol (2011) 1.86
Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization. J Mol Biol (2005) 1.80
EphA2 expression is associated with aggressive features in ovarian carcinoma. Clin Cancer Res (2004) 1.80
YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol (2008) 1.78
CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest (2002) 1.73
Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med (2009) 1.73
Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum (2007) 1.72
Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med (2009) 1.72
Programmed death-1 targeting can promote allograft survival. J Immunol (2002) 1.68
MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3. J Leukoc Biol (2007) 1.67
IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis. Am J Respir Crit Care Med (2015) 1.66
ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol (2008) 1.62
The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J Exp Med (2002) 1.62
Achieving asthma control in practice: understanding the reasons for poor control. Respir Med (2008) 1.61
Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J Exp Med (2008) 1.59
IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J Allergy Clin Immunol (2012) 1.59
Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest (2012) 1.58
Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol (2003) 1.57
Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma. J Allergy Clin Immunol (2003) 1.56
CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol (2008) 1.51
Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 1.49
Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol (2004) 1.49
Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol (2012) 1.45
MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS One (2009) 1.44
Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur J Immunol (2006) 1.42
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol (2013) 1.42
ALMA, a new tool for the management of asthma patients in clinical practice: development, validation and initial clinical findings. Prim Care Respir J (2012) 1.41
Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients. Respir Med (2010) 1.41
MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J Allergy Clin Immunol (2010) 1.41
Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J Exp Med (2002) 1.41
IL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One (2011) 1.37
Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema. J Clin Invest (2005) 1.37
Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency. Antimicrob Agents Chemother (2005) 1.32
B7-H3 promotes acute and chronic allograft rejection. Eur J Immunol (2005) 1.31
Nod1 participates in the innate immune response to Pseudomonas aeruginosa. J Biol Chem (2005) 1.29
IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax (2012) 1.26
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo. Cancer Res (2008) 1.25
Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane? Respir Res (2006) 1.25
CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J Immunol (2006) 1.25
Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J Infect Dis (2005) 1.23
Chronic inflammation and asthma. Mutat Res (2009) 1.22